(NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021.

However, the narrative for Pfizer appears to be changing. Its shares are up a respectable 9% year to date. The company reported better-than-expected second-quarter results on Tuesday. I think this Q2 update is much more important than only the headline numbers. Here's how Pfizer just confirmed it's a dividend investor's dream stock.

Anyone who has followed Pfizer lately knows it offers a high forward dividend yield of over 5.3%. The drugmaker has increased its dividend for 15 consecutive years. Income investors should love that Pfizer's management appears to solidly support keeping that streak going.

Continue reading

Source Fool.com